scPharmaceuticals Inc (SCPH)
3.49
+0.13
(+3.87%)
USD |
NASDAQ |
Nov 21, 16:00
3.49
0.00 (0.00%)
After-Hours: 18:01
scPharmaceuticals Price: 3.49 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 3.50 | 3.60 | 3.27 | 3.36 | 308929.0 |
Nov 19, 2024 | 3.30 | 3.58 | 3.245 | 3.52 | 374947.0 |
Nov 18, 2024 | 3.46 | 3.54 | 3.31 | 3.35 | 408156.0 |
Nov 15, 2024 | 3.32 | 3.48 | 3.075 | 3.46 | 1.592M |
Nov 14, 2024 | 3.50 | 3.65 | 3.25 | 3.36 | 4.153M |
Nov 13, 2024 | 4.01 | 4.01 | 3.80 | 3.91 | 409970.0 |
Nov 12, 2024 | 4.23 | 4.23 | 3.93 | 3.93 | 381826.0 |
Nov 11, 2024 | 4.25 | 4.25 | 4.17 | 4.23 | 140001.0 |
Nov 08, 2024 | 4.33 | 4.40 | 4.18 | 4.205 | 176093.0 |
Nov 07, 2024 | 4.35 | 4.50 | 4.26 | 4.32 | 223662.0 |
Nov 06, 2024 | 4.42 | 4.50 | 4.305 | 4.34 | 210729.0 |
Nov 05, 2024 | 4.02 | 4.08 | 4.02 | 4.07 | 94813.00 |
Nov 04, 2024 | 4.09 | 4.11 | 4.00 | 4.03 | 85717.00 |
Nov 01, 2024 | 4.21 | 4.27 | 4.05 | 4.07 | 146602.0 |
Oct 31, 2024 | 4.44 | 4.44 | 4.15 | 4.15 | 142553.0 |
Oct 30, 2024 | 4.44 | 4.60 | 4.39 | 4.46 | 314164.0 |
Oct 29, 2024 | 4.32 | 4.51 | 4.270 | 4.43 | 141442.0 |
Oct 28, 2024 | 4.26 | 4.51 | 4.26 | 4.37 | 193856.0 |
Oct 25, 2024 | 4.17 | 4.291 | 4.080 | 4.20 | 205884.0 |
Oct 24, 2024 | 4.37 | 4.41 | 4.060 | 4.18 | 339091.0 |
Oct 23, 2024 | 4.38 | 4.55 | 4.28 | 4.37 | 186065.0 |
Oct 22, 2024 | 4.43 | 4.60 | 4.39 | 4.41 | 122275.0 |
Oct 21, 2024 | 4.51 | 4.58 | 4.345 | 4.42 | 161658.0 |
Oct 18, 2024 | 4.39 | 4.55 | 4.33 | 4.53 | 160583.0 |
Oct 17, 2024 | 4.45 | 4.45 | 4.32 | 4.39 | 80206.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.35
Minimum
Nov 18 2024
11.74
Maximum
May 12 2023
6.391
Average
6.00
Median
Mar 19 2020
Price Benchmarks
NovaBay Pharmaceuticals Inc | 0.718 |
Palatin Technologies Inc | 0.91 |
iBio Inc | 2.45 |
Theriva Biologics Inc | 1.28 |
Oragenics Inc | 0.2703 |
Price Related Metrics
PS Ratio | 4.705 |
Price to Book Value | 5.687 |
Earnings Yield | -54.44% |
Market Cap | 174.64M |